Mast Cell-Mediated Antigen Presentation Regulates CD8+ T Cell Effector Functions

The characteristics, importance, and molecular requirements for interactions between mast cells (MCs) and CD8+ T cells have not been elucidated. Here, we demonstrated that MCs induced antigen-specific CD8+ T cell activation and proliferation. This process required direct cell contact and MHC class I...

Full description

Saved in:
Bibliographic Details
Published inImmunity (Cambridge, Mass.) Vol. 31; no. 4; pp. 665 - 676
Main Authors Stelekati, Erietta, Bahri, Rajia, D'Orlando, Orietta, Orinska, Zane, Mittrücker, Hans-Willi, Langenhaun, Rabea, Glatzel, Markus, Bollinger, Annalena, Paus, Ralf, Bulfone-Paus, Silvia
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 16.10.2009
Elsevier Limited
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The characteristics, importance, and molecular requirements for interactions between mast cells (MCs) and CD8+ T cells have not been elucidated. Here, we demonstrated that MCs induced antigen-specific CD8+ T cell activation and proliferation. This process required direct cell contact and MHC class I-dependent antigen cross-presentation by MCs and induced the secretion of interleukin-2, interferon-γ, and macrophage inflammatory protein-1α by CD8+ T cells. MCs regulated antigen-specific CD8+ T cell cytotoxicity by increasing granzyme B expression and by promoting CD8+ T cell degranulation. Because MCs also upregulated their expression of costimulatory molecules (4-1BB) and released osteopontin upon direct T cell contact, MC-T cell interactions probably are bidirectional. In vivo, adoptive transfer of antigen-pulsed MCs induced MHC class I-dependent, antigen-specific CD8+ T cell proliferation, and MCs regulated CD8+ T cell-specific priming in experimental autoimmune encephalomyelitis. Thus, MCs are important players in antigen-specific regulation of CD8+ T cells.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1074-7613
1097-4180
DOI:10.1016/j.immuni.2009.08.022